Safety Observer

January 2024

Safety Observer 207

The FDA has published new guidance documents on RWD and RWE.

Released 08-Jan-2024
Pages 35
Subscribe Highlights

Report 207 ā€” Highlights

FDA Guidance on RWD

The FDA has published new final guidance documents to help advance the use of RWD (Real-World Data) and RWE (Real-World Evidence) in the lifecycle of medicines.

FDA: Vaccine ICSRs

The FDA has released a new version of the Specifications for the electronic submission of ICSRs for Vaccines.

EU CTR guidance

A new version of the Q&As on the EU CTR (Clinical Trials Regulation (EU) NĀ°536/2014) has been published, which brings clarifications on applicable Safety Reporting requirements.

Learning events

The FDA, the MHRA and Health Canada will hold a joint GCP & PV Compliance Workshop from 13 to 15-Feb-2024, while a new MHRA GPvP Symposium will take place on 28-Feb-2024.

SO Service Update

The new web-based Reading Platform has been launched and over 10 clients and 100 users now access their Safety Observer reports through this new tool.

Sign up for alerts

Receive alerts and news on pharmacovigilance regulatory requirements every month.

Register today!

Safety Observer

EUR (€)
My account


3-Month Plan

This Plan includes three consecutive reports starting with the next release. The perfect solution to test the value of our service.

Starts at 180 

1-Year Plan

This Plan includes eleven consecutive reports starting with the next release. Includes a double issue for July/August.

Starts at 600 

Stay in the loop

Join over 1,000 Pharmacovigilance professionals and receive our Free Content straight to your mailbox !